[
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "R",
        "alt": "C",
        "position": "1441"
      },
      "variant_string_id": "LRRK2 R1441C"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper defines that LRRK2 is mutated in a significant number of Parkinson’s disease patients, and the study aims to understand how it is regulated or functions. In particular, the focus is on 14-3-3 protein interaction with LRRK2.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly states that LRRK2 mutations in Parkinson's disease are being studied and that the focus is on 14-3-3 protein interaction."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The study uses a protein interaction assay to investigate 14-3-3 protein interaction with LRRK2, which is widely accepted in the field.",
        "judgment": "Yes"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": {
          "3a - Basic Controls and Replicates": {
            "internal_question_1": "Yes",
            "internal_question_2": "Yes"
          },
          "3b - Accepted/Validated Assay": null,
          "3c - Variant Controls": {
            "internal_question": "Yes"
          }
        },
        "judgment": "Complete"
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": {
          "4a - Statistical Analyses": null,
          "4b - No OddsPath Calculation": null,
          "4c - Correlate OddsPath": {
            "internal_information": "The study reports that the R1441C mutation significantly reduces the interaction between LRRK2 and 14-3-3 proteins compared to wild type.",
            "judgment": "Not applicable as no OddsPath is calculated."
          }
        },
        "judgment": "Incomplete"
      }
    ],
    "overall_conclusion": "The study provides evidence that the R1441C mutation in LRRK2 reduces its interaction with 14-3-3 proteins, which is consistent with a pathogenic role. However, the functional evidence strength cannot be definitively classified based on the information provided in this paper."
  },
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "R",
        "alt": "A",
        "position": "1618"
      },
      "variant_string_id": "LRRK2 R1618A"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper defines that LRRK2 is mutated in a significant number of Parkinson’s disease patients, and the study aims to understand how it is regulated or functions. In particular, the focus is on 14-3-3 protein interaction with LRRK2.",
        "judgment": "Yes",
        "reasoning": "The paper explicitly states that LRRK2 mutations in Parkinson’s disease are being studied and that the focus is on 14-3-3 protein interaction."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The study uses a protein interaction assay to investigate 14-3-3 protein interaction with LRRK2, which is widely accepted in the field.",
        "judgment": "Yes"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": {
          "3a - Basic Controls and Replicates": {
            "internal_question_1": "Yes",
            "internal_question_2": "Yes"
          },
          "3b - Accepted/Validated Assay": null,
          "3c - Variant Controls": {
            "internal_question": "Yes"
          }
        },
        "judgment": "Complete"
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": {
          "4a - Statistical Analyses": null,
          "4b - No OddsPath Calculation": null,
          "4c - Correlate OddsPath": {
            "internal_information": "The study reports that the R1618A mutation significantly increases the interaction between LRRK2 and 14-3-3 proteins compared to wild type.",
            "judgment": "Not applicable as no OddsPath is calculated."
          }
        },
        "judgment": "Incomplete"
      }
    ],
    "overall_conclusion": "The study provides evidence that the R1618A mutation in LRRK2 increases its interaction with 14-3-3 proteins, which is consistent with a pathogenic role. However, the functional evidence strength cannot be definitively classified based on the information provided in this paper."
  }
]